(r)-2-Amino-3-(4-chloro-3-fluorophenyl)propanoic acid, 95%, 250mg

(S)-(-)-1-Ethyl-2-pyrrolidinecarboxamide, 98.0%, 5g

GLIPIZIDE, 95%, 25g

3-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-4-(trifluoromethyl)pyridine, 95.0%, 5g

Ethyl 4-tert-butylbenzoylformate, 96.0%, 1g

1,5-Dibromo-2-iodo-4-methoxybenzene, 98%, 10g

Methyl 3-(Diethylamino)propionate, 98%, 25g

Ethyl-5-oxooxepane-4-carboxylate, 95.0%, 1g

4-(3-Methoxybenzyl)piperidine hydrochloride, 95.0%, 250mg

rEGCase I assisted by Activator II1vial

2-(2-Bromoethoxy)-1-methoxybenzene, 97.0%, 250mg

4-Bromo-2-fluoro(trifluoromethoxy)benzene, 97.0%, 100g

(2-furylmethyl)(2-pyridinylmethyl)amine oxalate, 95.0%, 10g